4d pharma (4d pharma) Dividend Yield % : 0.00% (As of May. 31, 2024)

View and export this data going back to 2021. Start your Free Trial

What is 4d pharma Dividend Yield %?

As of today (2024-05-31), the Trailing Annual Dividend Yield of 4d pharma is 0.00%.

The historical rank and industry rank for 4d pharma's Dividend Yield % or its related term are showing as below:

LBPWQ's Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.52
* Ranked among companies with meaningful Dividend Yield % only.

4d pharma's Dividend Payout Ratio for the six months ended in Dec. 2021 was 0.00.

As of today (2024-05-31), the Forward Dividend Yield % of 4d pharma is 0.00%.

4d pharma's Dividends per Share for the six months ended in Dec. 2021 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

4d pharma Dividend Yield % Historical Data

The historical data trend for 4d pharma's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma Dividend Yield % Chart

4d pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dividend Yield %

Get a 7-Day Free Trial

4d pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
Dividend Yield %	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of 4d pharma's Dividend Yield %

For the Biotechnology subindustry, 4d pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4d pharma's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4d pharma's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where 4d pharma's Dividend Yield % falls into.

4d pharma Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

4d pharma (OTCPK:LBPWQ) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

4d pharma Dividend Yield % Related Terms

Thank you for viewing the detailed overview of 4d pharma's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

4d pharma (4d pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ

Website

https://www.4dpharmaplc.com

4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.